Resultados de procura - Ihsan Nijem
- Mostrando 1 - 4 Resultados de 4
-
1
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer por Whitney P. Kirschbrown, Bei Wang, Ihsan Nijem, Atsushi Ohtsu, Paulo M. Hoff, Manish A. Shah, Lin Shen, Yoon‐Koo Kang, María Alsina, Sandhya Girish, Amit Garg
Publicado 2019Artigo -
2
Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies por Ravi Salgia, Premal H. Patel, John Bothos, Wei Yu, Steve Eppler, Priti S. Hegde, Shuang Bai, Surinder Kaur, Ihsan Nijem, Daniel V.T. Catenacci, Amy Peterson, Mark J. Ratain, Blasé N. Polite, Janice M. Mehnert, Rebecca A. Moss
Publicado 2014Artigo -
3
Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study por Whitney P. Kirschbrown, Matts Kågedal, Bei Wang, Lars Lindbom, Adam Knott, Rachelle Mack, Sharareh Monemi, Ihsan Nijem, Sandhya Girish, Christie Freeman, Debora Fumagalli, Robin McConnell, Guy Jérusalem, Chris Twelves, José Baselga, Gϋnter von Minckwitz, José Bines, Amit Garg
Publicado 2019Artigo -
4
Charge variants in IgG1 por Leslie A. Khawli, Sirj Goswami, Ryan Hutchinson, Zephania W. Kwong, Jihong Yang, Xiangdan Wang, Zhenling Yao, Alavattam Sreedhara, Tony Cano, Devin B. Tesar, Ihsan Nijem, David E. Allison, Pin Yee Wong, Yung‐Hsiang Kao, Cynthia Quan, Amita Joshi, Reed J. Harris, Paul A. Motchnik
Publicado 2010Artigo
Ferramentas de procura:
Materias Relacionadas
Pharmacokinetics
Internal medicine
Medicine
Pharmacology
Breast cancer
Cancer
Cmax
Gastroenterology
Oncology
Pertuzumab
Trastuzumab
Adenocarcinoma
Alternative medicine
Antibody
Bevacizumab
Biochemistry
Biological activity
Biology
Biophysics
Chemistry
Chemotherapy
Cmin
Environmental health
Gastroesophageal Junction
Gene
Genetics
Immunology
In vitro
In vivo
Monoclonal antibody